NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians

New survey from NCCN finds cancer drug shortage management remains a moving target

oncologynews.com.au - 15:24

The National Comprehensive Cancer Network® (NCCN®) in the USA is publishing new results for its latest survey on cancer drug shortages in the...

Cross-border network of European specialists provides new treatment options for women with complex rare gynaecological cancers

oncologynews.com.au - 24/Jun 16:01

Cross-border tumour boards of cancer specialists from different European countries meeting virtually to review the management of individual patients...

People with ADHD Often Remain Silent About Their Diagnosis

medindia.net - 19/Jun 22:54

Nearly 53 percent people with Attention Deficit Hyperactivity Disorder (ADHD) remain silent about their diagnosis. Almost 66 percent of young women...

Endometrial Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:16

DelveInsight’s, “Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies...

Peritoneal Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:12

DelveInsight’s, “Peritoneal Cancer Pipeline Insight 2024” report provides comprehensive insights about 55+ companies...

2019 to 2020 Saw Increase in Rate of Firearm Injury EMS Encounters

drugs.com - 21/Jun 15:06

FRIDAY, June 21, 2024 -- The rate of firearm injury emergency medical services (EMS) encounters increased from 2019 to 2020 and remained elevated...

Study Quantifies Risk for Gastric, Breast Cancer for Germline CDH1 P/LP Variants

drugs.com - 21/Jun 15:06

FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1...

Advanced Kidney Cancer Pipeline Report 2024 | Clinical Trials, FDA, EMA, PMDA Approvals, Drugs and Companies

mountaintoday.in - 17/Jun 18:52

DelveInsight’s, “Advanced Kidney Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+...

Thyroid Cancer Pipeline Report 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA

mountaintoday.in - 19/Jun 15:08

DelveInsight’s, “Thyroid Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 51+ pipeline...

Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer

oncologynews.com.au - 25/Jun 12:27

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...

Rubriques :